Molecular Tumour Board

The VCCC Molecular Tumour Board (MTB) is a multi-disciplinary style forum that provides opinion on the clinical implications of molecular pathology test results of tumours.

Each case is discussed on an individual, de-identified basis. Most MTB meetings also feature an educational presentation.

Discussion and assessment of molecular pathology results

The MTB is convened by Associate Professor Jayesh Desai and Dr Ben Tran with an expert group comprised of clinical and scientific staff from across the VCCC providing opinion on each case.  

The MTB educational and research presentations provide an excellent opportunity to learn more about personalised medicine. CPD points are available for meeting attendance. The MTB welcomes referrals from any clinician or multi-disciplinary team from VCCC members and collaborators.

Clinicians, scientists and students (from any organisation) are welcome to attend the meetings, which are usually held on Fridays. No RSVP is required. 

If you would like to receive meeting agendas, be added to the mailing list or have other enquiries, please contact Imogen Elsum, VCCC Program Manager.

Meeting details

VCCC building, 305 Grattan St, Lecture Theatre A, Level 7, 2:45-4pm 

Or join us via webinar  

Friday 19 July

Education presentation

Cancers of unknown primary (CUP) and molecular testing: future directions

• Dr Richard Tothill, The University of Melbourne

Clinical presentation (to be confirmed)

Friday 16 August

Education presentation 

Structures reveal how acquired BCL2 mutations confer resistance to venetoclax

• Dr Richard Birkinshaw, The Walter and Eliza Hall Institute of Medical Research 

Clinical presentation (to be confirmed)

Friday 20 September

Education presentation 

Cancer Diagnoses following Abnormal Cell-Free DNA on Non-Invasive Prenatal Testing

• Dr Eryn Dow, Peter MacCallum Cancer Centre 

Clinical presentation (to be confirmed)

Friday 18 October 

Education presentation 

Challenges in the translation of biomarkers and genomics technologies to precision oncology services 

• Professor Maarten Ijzerman, The University of Melbourne

Clinical presentation (to be confirmed)

Future dates, speakers to be confirmed

Friday 15 November  
Friday 20 December 

Case submission

We welcome cases from clinicians whose patients have had molecular pathology testing performed as part of clinical care or research. Experts will provide advice and opinion regarding the clinical implications of the molecular pathology findings. Wherever possible, referring clinicians will also be advised on appropriate available clinical trials.

To submit a case to the MTB, please complete the MTB case form template and send via email to Imogen Elsum, VCCC Program Manager.